IQVIA™ Real-World Insights Bibliography

Real-Life Cost Analysis of Anemia Treatment with Erythropoiesis Stimulating Agents In Cancer Patients Receiving Chemotherapy
Author(s): Duran A1, Spaepen E2, Lamotte M3, Walter E4, Kutikova L5, Pujol B5, Annemans L6
Affiliations(s): 1 IMS Health, London, UK; 2 SBD Analytics BVBA/SPRL, Belgium; 3 IMS Health, Brussels, Belgium; 4 Institut fuer Pharmacoekonomische Forschung, Vienna, Austria; 5 Amgen (Europe) GmbH, Zug, Switzerland; 6 I-CHER Interuniversity Centre for Health Economics Research, Gent, Belgium
Publication(s):  American Society of Hematology. December 4-7, 2010 Orlando, FL. USA
Document Type(s): Poster,
Countries: Austria,
C:
Y:
Oncology,
2010
  L:
A:
English
Cost analysis,
  Add to report
 
 
Pharmacoeconomic evaluation of ranibizumab in the treatment of age-related macular degeneration in Austria.
Author(s): Walter E, Brennig C, Moeremans K, Thomas V
Affiliations(s): 
Publication(s):  ISPOR 11th Annual International Meeting, 2008, November 8-11, Athens, Greece
Document Type(s): Poster,
Countries: Austria,
C:
Y:
Ophthalmology,
2008
  L:
A:
English
Cost utility,
  Add to report
 
 
Health care-associated rotavirus illness in pediatric inpatients in Germany, Austria, and Switzerland.
Author(s): Foppa I, Karmaus W, Ehlken B, Fruhwirth M, Heiniger U, Plenge-Bonig A, Forster J.
Affiliations(s): 
Publication(s):  Infect Control Hosp Epidemiol. 2006; 27(6): 633-5.
Document Type(s): Article,
Countries: Austria, Germany, Switzerland,
C:
Y:
Infectious disease,
2006
  L:
A:
English
Epidemiological study,
  Add to report
 
 
First Page Previous Page  2 of 2